Agile Therapeutics(AGRX) - 2019 Q4 - Annual Report
AGRXAgile Therapeutics(AGRX)2020-02-21 05:36

Use these links to rapidly review the document Table of Contents Item 8. Financial Statements and Supplementary Data Title of each class Trading Symbol(s) Name of exchange on which registered: Common stock, par value $0.0001 per share AGRX The Nasdaq Capital Market Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2019 OR o TRANSITION REPORT ...